HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Western and Central Africa  /  NER

Niger

Niger's health statistics yearbooks, published through the national statistics institute, count people on antiretroviral treatment at 31 December in all eight regions, citing the national HIV programme. Our project reads the regional treatment table from the yearbooks for 2013 to 2024. The 2015 yearbook is excluded because the age columns of the 2015 yearbook do not add up to the national row, so the Niger series has no point for 2015. PEPFAR does not report below the national level in Niger, so the health statistics yearbooks are the panel's only regional record of treatment in Niger.

32,000
People living with HIV, 2025
WHO Global Health Observatory
66.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$2.5m
United States HIV disbursements, 2026
ForeignAssistance.gov
$14.0m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$5m$10m$15m200220052008201120142017202020232026$14.0m$5.1m$8.0m$2.5m
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $323k — — —
2003 $1.7m — — —
2004 $6.2m — $2.2m —
2005 $5.3m — $2.5m —
2006 $5.2m — $2.0m —
2007 $7.5m — $2.8m —
2008 $8.9m — $5.3m —
2009 $13.0m — $6.7m —
2010 $6.4m $83k $1.3m $36k
2011 $13.2m — $5.4m $54k
2012 $8.1m $153k $3.2m $67k
2013 $9.7m $82k $4.8m $174k
2014 $5.2m $181k $2.6m $181k
2015 $9.5m — $4.9m $11k
2016 $5.8m $116k $4.0m $96k
2017 $7.6m $271k $6.4m $305k
2018 $4.5m $212k $3.9m $212k
2019 $6.2m $619k $5.2m $619k
2020 $7.6m $1.0m $6.0m $902k
2021 $6.0m — $4.0m $434k
2022 $16.9m $5k $15.8m $247k
2023 $14.9m $997k $12.6m $1.3m
2024 $14.0m $5.1m $8.0m $374k
2025 — — — $8.2m
2026 — — — $2.5m

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
020k40k20002003200620092012201520182021202432,00021,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 46,000 39,000 52,000 —
2001 46,000 39,000 53,000 —
2002 46,000 39,000 52,000 —
2003 45,000 39,000 51,000 —
2004 44,000 38,000 50,000 —
2005 43,000 38,000 49,000 —
2006 42,000 37,000 48,000 —
2007 41,000 36,000 46,000 —
2008 40,000 35,000 45,000 —
2009 39,000 35,000 44,000 —
2010 38,000 34,000 43,000 7,300
2011 37,000 33,000 42,000 9,400
2012 36,000 32,000 41,000 11,000
2013 35,000 32,000 40,000 12,000
2014 35,000 31,000 39,000 11,000
2015 34,000 30,000 38,000 13,000
2016 33,000 30,000 37,000 15,000
2017 33,000 29,000 37,000 17,000
2018 32,000 29,000 37,000 20,000
2019 32,000 29,000 36,000 20,000
2020 32,000 29,000 36,000 21,000
2021 32,000 29,000 36,000 22,000
2022 32,000 29,000 36,000 22,000
2023 32,000 28,000 36,000 22,000
2024 32,000 28,000 36,000 21,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%20%40%60%80%2010201220142016201820202022202480.0%66.0%52.0%
  • Diagnosed
  • On treatment
  • Virally suppressed
YearDiagnosedOn treatmentVirally suppressed
2010 24.0% 19.0% —
2011 32.0% 26.0% —
2012 39.0% 31.0% —
2013 45.0% 34.0% —
2014 49.0% 33.0% —
2015 54.0% 38.0% —
2016 58.0% 44.0% —
2017 62.0% 53.0% 44.0%
2018 67.0% 61.0% 54.0%
2019 70.0% 63.0% 46.0%
2020 73.0% 66.0% 52.0%
2021 76.0% 68.0% 54.0%
2022 78.0% 69.0% 52.0%
2023 78.0% 69.0% 52.0%
2024 80.0% 66.0% —

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

The national programme record
Niger health statistics yearbook
010k20k20132014201520162017201820192020202120222023202421,151
  • Number of people on ART (PEPFAR MER TX_CURR)
YearNumber of people on ART (PEPFAR MER TX_CURR)
2013 12,071
2014 11,286
2016 15,265
2017 18,425
2018 19,793
2019 20,427
2020 21,330
2021 24,292
2022 25,243
2023 22,109
2024 21,151

11 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Counts read directly from the national programme's own publication. The counts come from a programme register and are not modelled estimates, so the counts will not match the international series exactly. The 2015 yearbook is excluded because the age columns of the 2015 yearbook do not add up to the national row, so the line has a gap at 2015.

Sources of the figures for Niger

3,817 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 803 28 2000–2024 aidsinfo.unaids.org 2026-10-20
Niger health statistics yearbook Programme record 477 1 2013–2024 stat-niger.org 2026-10-12
WHO Global Health Observatory Modelled estimate 265 12 2000–2025 ghoapi.azureedge.net 2026-10-12
UNAIDS HIV sub-national estimates viewer (Naomi) Modelled estimate 189 7 2025 nmviewerserver.azurewebsites.net 2026-10-14
WHO Global Tuberculosis Programme Programme record 131 16 2000–2025 extranet.who.int 2026-10-16
Demographic and Health Surveys Survey 127 4 2006–2012 api.dhsprogram.com 2026-10-16
Global Fund Data Service Programme record 85 9 2017–2025 fetch.theglobalfund.org 2026-10-12
WHO Global Health Expenditure Database Expenditure account 77 7 2013–2023 apps.who.int 2026-10-12
IATI, through d-portal Expenditure account 61 3 2004–2026 d-portal.org 2026-10-12
OECD Creditor Reporting System Expenditure account 56 3 2002–2024 sdmx.oecd.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
WHO HIV testing services dashboard Programme record 44 5 2018–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
ForeignAssistance.gov Expenditure account 42 4 2010–2026 foreignassistance.gov 2026-10-29
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 22 7 2013–2021 hivfinancial.unaids.org 2026-10-12
UNAIDS Data 2025 country databook Expenditure account 7 3 2015–2021 aidsinfo.unaids.org 2026-10-15
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12

Indicators held

74 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 3 2019–2021 WHO Global Tuberculosis Programme $725 (2021)
Budget required for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $919k (2025)
Country-reported HIV expenditure, all sources Financing USD 12 2012–2023 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $9.9m (2023)
Domestic funding received by the national TB programme Financing USD 2 2022–2023 WHO Global Tuberculosis Programme $527k (2023)
Domestic public HIV expenditure Financing USD 8 2013–2021 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $688k (2021)
Expected Global Fund funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $4.6m (2025)
Expected USAID funding for the national TB programme Financing USD 1 2025 WHO Global Tuberculosis Programme $0 (2025)
Expected domestic funding for the national TB programme Financing USD 4 2018–2025 WHO Global Tuberculosis Programme $1.3m (2025)
Expected funding for collaborative TB/HIV activities Financing USD 6 2018–2025 WHO Global Tuberculosis Programme $392k (2025)
External HIV and STD spending, national health accounts Financing USD 11 2013–2023 WHO Global Health Expenditure Database $922k (2023)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $14.0m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 22 2005–2026 IATI, through d-portal $26k (2026)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 16 2011–2026 IATI, through d-portal $437k (2026)
External HIV financing from the United States (ODA) Financing USD 29 2010–2026 ForeignAssistance.gov, OECD Creditor Reporting System $2.5m (2026)
Funding received for collaborative TB/HIV activities Financing USD 3 2019–2021 WHO Global Tuberculosis Programme $2k (2021)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 17,188,190 (2026)
Global Fund HIV disbursements to the country Financing USD 45 2004–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $5.6m (2026)
Global Fund funding received by the national TB programme Financing USD 6 2018–2023 WHO Global Tuberculosis Programme $1.5m (2023)
Government HIV and STD spending as a share of government health spending Financing percent 11 2013–2023 WHO Global Health Expenditure Database 0.8% (2023)
Government HIV and STD spending, national health accounts Financing USD 11 2013–2023 WHO Global Health Expenditure Database $1.3m (2023)
HIV and STD spending as a share of all external health spending Financing percent 11 2013–2023 WHO Global Health Expenditure Database 0.9% (2023)
HIV and STD spending as a share of all health spending Financing percent 11 2013–2023 WHO Global Health Expenditure Database 0.5% (2023)
HIV and STD spending, national health accounts Financing USD 11 2013–2023 WHO Global Health Expenditure Database $3.5m (2023)
HIV spending on treatment, care and support Financing USD 1 2021 UNAIDS Global AIDS Monitoring expenditure database $4.5m (2021)
International HIV expenditure (country-reported) Financing USD 8 2013–2021 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $3.8m (2021)
Other bilateral HIV expenditure (country-reported) Financing USD 2 2013–2014 UNAIDS Global AIDS Monitoring expenditure database $3.1m (2014)
Private HIV and STD spending, national health accounts Financing USD 11 2013–2023 WHO Global Health Expenditure Database $1.3m (2023)
Private HIV expenditure (country-reported) Financing USD 4 2013–2015 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $3k (2015)
US HIV disbursements managed by USAID Financing USD 7 2020–2026 ForeignAssistance.gov $-1 (2026)
US HIV disbursements managed by other US agencies Financing USD 17 2010–2026 ForeignAssistance.gov $91k (2026)
US HIV disbursements managed by the State Department Financing USD 1 2026 ForeignAssistance.gov $2.4m (2026)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 15 2017–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 50.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 96 2000–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory 66.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 55 2010–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory 80.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 20 2005–2024 UNAIDS AIDSinfo 61.9% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 1 2022 UNAIDS AIDSinfo 9.5% (2022)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 7 2014–2024 UNAIDS AIDSinfo 12.1% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 5 2015–2024 UNAIDS AIDSinfo 61.9% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 8 2017–2025 WHO Global Health Observatory 75.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 32 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 0.5% (2024)
HIV self-test kits distributed Treatment cascade count 2 2023–2024 WHO HIV testing services dashboard 2,730 (2024)
HIV tests performed at a health facility Treatment cascade count 5 2019–2024 WHO HIV testing services dashboard 1,504,691 (2024)
HIV tests performed through community outreach Treatment cascade count 5 2019–2024 WHO HIV testing services dashboard 25,872 (2024)
HIV tests performed with the result returned to the person Treatment cascade count 40 2017–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 1,530,563 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 13 2012–2024 UNAIDS AIDSinfo 20.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 19 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 272 (2025)
Key-population people tested for HIV (count over the period) Treatment cascade count 17 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 5 2016–2020 UNAIDS AIDSinfo 35.0% (2020)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 581 2000–2025 Global Fund Data Service, Niger health statistics yearbook, UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), WHO Global Health Observatory, WHO Global Tuberculosis Programme 21,057 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 49.0% (2025)
People living with HIV in care screened for TB Treatment cascade count 4 2017–2020 Global Fund Data Service 2,123 (2020)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 3 2022–2024 Global Fund Data Service 1,847 (2024)
People newly enrolled on ART during the year Treatment cascade count 9 2014–2024 WHO Global Tuberculosis Programme 2,908 (2024)
People tested for HIV in the last 12 months who received the result (household survey) Treatment cascade percent 36 2006–2012 Demographic and Health Surveys By population group, sex or age only, to 2012
Pregnant women tested for HIV in antenatal care Treatment cascade percent 8 2017–2024 UNAIDS AIDSinfo 95.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 40 2010–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory 982 (2025)
TB patients recorded as HIV-positive Treatment cascade count 10 2015–2024 WHO Global Tuberculosis Programme 351 (2024)
TB patients with an HIV test result recorded Treatment cascade count 19 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 15,233 (2025)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 890 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 160 (2024)
HIV prevalence among a key population Epidemic estimates percent 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 122 2000–2025 Demographic and Health Surveys, UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), World Bank Open Data 0.1% (2025)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 530 (2024)
New HIV infections Epidemic estimates count 612 2000–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), UNICEF HIV/AIDS dataset, WHO Global Health Observatory 1,500 (2025)
People living with HIV Epidemic estimates count 708 2000–2025 UNAIDS AIDSinfo, UNAIDS HIV sub-national estimates viewer (Naomi), UNICEF HIV/AIDS dataset, WHO Global Health Observatory 32,000 (2025)
Condom use at last higher-risk sex (household survey) Prevention and outreach percent 6 2006–2012 Demographic and Health Surveys By population group, sex or age only, to 2012
Key-population members reached by prevention programmes Prevention and outreach percent 2 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Key-population people reached by outreach (count over the period) Prevention and outreach count 17 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
Male condoms distributed in a year Prevention and outreach count 5 2019–2024 UNAIDS AIDSinfo 2,025,045 (2024)
People with comprehensive correct knowledge of HIV (household survey) Prevention and outreach percent 40 2006–2012 Demographic and Health Surveys By population group, sex or age only, to 2012
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 2,000 (2025)
Estimated size of a key population Population denominators count 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 53 2000–2025 UNAIDS HIV sub-national estimates viewer (Naomi), World Bank Open Data 27,917,831 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 25.2% (2025)

Every row shown on the Niger page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.